Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
Clinical trial NCT01982955 · COMPLETED
Trial details
- NCT number
- NCT01982955
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-23
- Primary completion
- 2017-12-12
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.